← Back
Data updated: Mar 29, 2026
ITERUM THERAP
Infectious Disease
Pharma
ITERUM THERAP is a pharmaceutical company focused on Infectious Disease. Key products include ORLYNVAH.
2024
Since
1
Drugs
-
Trials
3
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
ORLYNVAH 2025-12-23
Labeling
ORLYNVAH 2025-03-24
Labeling
ORLYNVAH 2024-10-25
Type 1 - New Molecular Entity and Type 4 - New Combination
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
1 drugs Phase 3: 5 Phase 1: 2
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-10-25
- Latest
- 2025-12-23
- Applications
- 1